BG51697A1 - Parentral formulation with extended action and method for its preparation - Google Patents

Parentral formulation with extended action and method for its preparation

Info

Publication number
BG51697A1
BG51697A1 BG9487591A BG9487591A BG51697A1 BG 51697 A1 BG51697 A1 BG 51697A1 BG 9487591 A BG9487591 A BG 9487591A BG 9487591 A BG9487591 A BG 9487591A BG 51697 A1 BG51697 A1 BG 51697A1
Authority
BG
Bulgaria
Prior art keywords
albumen
parentral
formulation
preparation
methylprednisolone
Prior art date
Application number
BG9487591A
Inventor
Valja P Dilova
Marija G Tomova
Valentina I Shishkova
Ginka N Kalinova
Original Assignee
Dilova
Tomova
Shishkova
Kalinova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilova, Tomova, Shishkova, Kalinova filed Critical Dilova
Priority to BG9487591A priority Critical patent/BG51697A1/en
Publication of BG51697A1 publication Critical patent/BG51697A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The parentheral drug is used in veterinary practice. It extends the action of the active substance to seven days upon bio-compatibility with the human body. In effect, these are bio-disintegrating microspheres that are between 1 to 200 mkm in size. They are made of denaturated beef serum albumen and 9 α-fluoro-16 α-methylprednisolone in proportion of 10/0.5 to 10/2 weight parts. The method includes mixing of the water albumen suspension and 9 α-fluoro-16 α-methylprednisolone in oil phase in proportion of 1/100 to 10/100 vol. parts at 100 to 1,500 degrees C and mixing until full albumen meshing and infiltration.
BG9487591A 1991-07-23 1991-07-23 Parentral formulation with extended action and method for its preparation BG51697A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG9487591A BG51697A1 (en) 1991-07-23 1991-07-23 Parentral formulation with extended action and method for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG9487591A BG51697A1 (en) 1991-07-23 1991-07-23 Parentral formulation with extended action and method for its preparation

Publications (1)

Publication Number Publication Date
BG51697A1 true BG51697A1 (en) 1993-08-16

Family

ID=3923906

Family Applications (1)

Application Number Title Priority Date Filing Date
BG9487591A BG51697A1 (en) 1991-07-23 1991-07-23 Parentral formulation with extended action and method for its preparation

Country Status (1)

Country Link
BG (1) BG51697A1 (en)

Similar Documents

Publication Publication Date Title
FI956312A0 (en) Protein-encapsulated insoluble gas microspheres and their preparation and use as ultrasound imaging aids
DE3771091D1 (en) SLOW RELEASE FORMULATION.
DE68906153D1 (en) HUMANES RELAXATION DEVICE.
BR9301314A (en) EMULSION OF OIL IN WATER SAME USE
KR840000228A (en) Method for preparing dry powder in preparation mixture
ATE66366T1 (en) PREPARATION CONTAINING CORTICOIDS FOR TOPICAL APPLICATION.
ATE154822T1 (en) PREPARATIONS OF FAT SOLUBLE SUBSTANCES
YU215090A (en) PULLED FORMULATION FOR CONTROLLED RELEASE
MD1432C2 (en) Method of treatment of the state depending on the ovarian estrogens
KR890011609A (en) Live vaccine against spores by using a parasitoid
NO864062L (en) HETROCYCLIC COMPOUNDS AND PREPARATION AND APPLICATION OF THESE.
IL73958A0 (en) Contrast agents and method of use thereof
NL300330I1 (en) Preparation for delivering peptides
GR3016994T3 (en) Ultrasound-mediated administration of compounds into aquatic animals.
SE8505047D0 (en) fat emulsion
EP0295402A3 (en) Latex for immobilization of physiologically active substance and latex reagent using the latex
BG51697A1 (en) Parentral formulation with extended action and method for its preparation
SE7601535L (en) INJECTIBLE ANTIBIOTIC COMPOSITIONS
DE68916956D1 (en) ACTIVE AGENT: LIPID COMPLEX WITH HIGH RATIO.
DE3784628D1 (en) DERMAL TREATMENT OF CAT WORM DISEASES WITH PRAZIQUANTEL.
KR870010082A (en) Guar powder
MA21895A1 (en) ASSOCIATION OF VITAMIN "A" WITH PHYSIOLOGICAL DOSE AND DIFFERENT ACTIVE INGREDIENTS.
Thomas et al. Preliminary studies with azapropazone in gout and hyperuricaemia
Akuginova Combination of antihelminthic drugs (phenasal and bithionole) for therapy of cestode inections. II. Investigation of the effectiveness of bithionole and of combination of bithionole with phenasal in treatment of taeniarhynchosis
ES2056801T3 (en) OXYRANO-Pseudo-OLIGOSACCHARIDES, PROCEDURE FOR ITS PREPARATION, ITS USE AND PHARMACEUTICAL PREPARATIONS.